UroGen Pharma is a biopharmaceutical company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options.

Biotechnology

UroGen Pharma

UroGen Pharma's headquarters in Princeton, NJ, United States

Liz Barrett

Jim Ottinger

Will Batenic

Silvio Pacheco

Timothy Simon

Pasqual Zottola

Chris Degnan

Marina Konorty

Peter Maruszewski

Bryon Wornson

Jason Smith

Mark P. Schoenberg

Leana S. Wen

Fred E. Cohen

Stuart Holden

Ran Nussbaum

Arie Belldegrun

Dan Wildman

James Robinson

The Leadership Team at UroGen Pharma is responsible for shaping the strategic direction of the company, overseeing operations across manufacturing, research, and clinical development, and ensuring compliance with regulatory standards. By integrating cross-functional expertise, this team drives innovation in treating specialty cancers and urologic diseases while enhancing operational efficiency and fostering a culture of collaboration and advocacy. Together, they aim to deliver novel therapeutics that provide patients with better treatment options and improve health outcomes.

Leadership Team

The Sales and Business Development team at UroGen Pharma is responsible for driving the commercialization of innovative therapies for specialty cancers and urologic diseases. This team actively engages with healthcare providers, builds strong key account relationships, and works to expand market access. By leveraging a deep understanding of the biopharmaceutical landscape, they aim to enhance patient access to UroGen's groundbreaking treatments through strategic sales initiatives and collaboration across the organization.

Sales and Business Development

The Clinical and Medical Affairs team at UroGen Pharma is responsible for bridging research and clinical practice, ensuring the scientific integrity and strategic communication of the company’s novel therapies. They oversee clinical trials, engage with healthcare professionals to provide insights on treatment options, and manage the documentation and regulatory compliance necessary for bringing innovative solutions to market. Additionally, team members collaborate closely with other departments to drive the development and implementation of effective medical strategies that align with the company's mission to improve patient outcomes in specialty cancers and urologic diseases.

Clinical and Medical Affairs

The Finance and Accounting team at UroGen Pharma is responsible for managing the company's financial health, ensuring accurate financial reporting, and overseeing budgeting and forecasting processes. They play a critical role in strategic decision-making by providing financial insights and compliance oversight, enabling the company to allocate resources effectively in support of its mission to advance innovative treatments for specialty cancers and urologic diseases.

Finance and Accounting

The Project Management and Operations team at UroGen Pharma is responsible for overseeing and coordinating cross-functional projects related to the development and commercialization of biopharmaceutical products. This team ensures efficient collaboration among manufacturing, regulatory, and operational functions, optimizing processes to meet critical timelines and compliance requirements, ultimately enhancing patient outcomes in specialty cancer and urologic disease treatments.

��

UroGen Pharma

Org chart

Board & advisors

Teams

Leadership Team

Sales and Business Development

Clinical and Medical Affairs

Finance and Accounting

Project Management and Operations

Offices

��������

UroGen Pharma

Org chart

Board & advisors

Teams

Leadership Team

Sales and Business Development

Clinical and Medical Affairs

Finance and Accounting

Project Management and Operations

Offices

Related companies

��